After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. The current market capitalization of Abbvie Inc is $342.31B. A total of 6.14 million shares were traded on the day, compared to an average of 7.59M shares.
In the most recent transaction, Stewart Jeffrey Ryan sold 58,832 shares of ABBV for 210.08 per share on Mar 31 ’25. After the transaction, the EVP, CHIEF COMMERCIAL OFFICER now owns 53,234 company shares. In a previous transaction on Mar 31 ’25, Stewart Jeffrey Ryan bought 58,832 shares at 210.09 per share.
Among the insiders who sold shares, Reents Scott T disposed of 17,644 shares on Mar 14 ’25 at a per-share price of $212.34. This resulted in the EVP, CHIEF FINANCIAL OFFICER holding 11,577 shares of ABBV after the transaction. In another insider transaction, Reents Scott T bought 17,644 shares at $212.35 per share on Mar 14 ’25.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Abbvie Inc pays an annual dividend of $6.38, resulting in a dividend yield of 3.30%, and it has a price to earnings (P/E) ratio of 82.32. ABBV’s most recent ex-dividend date was 3.4% when it declared a $1.64 quarterly dividend that was paid in cash on 4/15/2025. Previously, the company paid the dividend on 1/15/2025 with an ex-dividend date of 3.46%. The ABBV stock dividend was $1.64 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ABBV has a high of $218.66 and a low of $153.58.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ABBV’s latest balance sheet shows that the firm has $9.83B in Cash & Short Term Investments as of fiscal 2021. There were $76.68B in debt and $35.19B in liabilities at the time. Its Book Value Per Share was $1.88, while its Total Shareholder’s Equity was $15.44B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABBV is Buy with a score of 4.23.
